• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Prostatic paracoccidioidomycosis: differential diagnosis of prostate cancer
Prostatic paracoccidioidomycosis: differential diagnosis of prostate cancer

... were concomitant conditions in this case, could be potential factors, in addition to prostate fibrosis induced by PCM (Brito & Carpini 1959). There is no report of alterations in serum levels of the prostatic-specific antigen PSA during the treatment. In granulomatous prostatitis, both increasing an ...
Diffusion Imaging of the Prostate at 3.0 Tesla
Diffusion Imaging of the Prostate at 3.0 Tesla

... rostate cancer is one of the commonest forms of malignancy in men with an incident rate that has risen dramatically during the last few years. This increase is primarily as a result of the increasing prevalence in the younger-than 65 age group.1 Management of prostatic carcinoma is guided by digital ...
Metabolic Syndrome Predicts Prostate Cancer in a Cohort of Middle
Metabolic Syndrome Predicts Prostate Cancer in a Cohort of Middle

... in Norway, and the research information on the association of IGF-1 and related factors to prostate cancer is the background for this paper’s focus on metabolic syndrome as a predictor of prostate cancer. The incidence of prostate cancer is, however, influenced by opportunistic screening. To what ex ...
Precise, Minimally Invasive Prostate Cancer Removal
Precise, Minimally Invasive Prostate Cancer Removal

... While clinical studies support the effectiveness of the da Vinci Surgical System when used in minimally invasive surgery, individual results may vary. There are no guarantees of outcome. All surgeries involve the risk of major complications. Before you decide on surgery, discuss treatment options wi ...
Prostate Cancer
Prostate Cancer

... under control. As you learn more about this disease, you’ll better understand what it means for your future. You can also learn ways to live well with prostate cancer. This booklet is not intended as a substitute for professional medical care. Only your doctor can diagnose and treat a medical proble ...
Risk Factors for Prostate Cancer
Risk Factors for Prostate Cancer

... Abstract: Prostate cancer is one of the representative cancers that show a marked difference in morbidity by race and region. In the U.S.A., the annual frequency for the diagnosis of prostate cancer is ranked first among all cancers excluding skin cancer, and it is the second leading cause of death ...
apcr annual review 2014 - Australian Prostate Cancer Research
apcr annual review 2014 - Australian Prostate Cancer Research

... Australian Prostate Cancer Research is proudly ringing in a new era in healthcare for men. The Australian Centre for Prostate Cancer & Men’s Health will launch in November 2014, setting a new benchmark for comprehensive prostate cancer and men’s health care, and addressing a massive unmet need in he ...
Low dose rate brachytherapy for the treatment of prostate cancer
Low dose rate brachytherapy for the treatment of prostate cancer

... The volume of prostate cancer within the prostate gland can be estimated by the histopathologist when the biopsy is analysed. Ideally patients should have an estimated small volume of prostate cancer although larger volumes can also be treated. ...
Benign Causes of Diffusion Restriction Foci in the Peripheral Zone
Benign Causes of Diffusion Restriction Foci in the Peripheral Zone

... •  Prostate  cancer  is  the  most  frequently  diagnosed   form  of  noncutaneous  cancer  in  men   •  American  Cancer  Society  es3mates  about   220,800  new  cases  of  prostate  cancer  for  2015   •  Second  leading  cause  of  canc ...
Obstruction - Dr Gerald Tan
Obstruction - Dr Gerald Tan

... For most patients with early prostate obstruction, their symptoms are usually well controlled with medications known as alpha-blockers, which act on receptors in the bladder neck to relax the bladder outlet during urination. For men with large prostate glands (more than 40gm in size), combination th ...
Prostate Cancer: Diagnosis and Treatment Information for Patients
Prostate Cancer: Diagnosis and Treatment Information for Patients

... in patients with prostate cancer. The surgeon makes four or five small incisions in a fan shape across the upper abdomen. A camera is inserted through one of the incisions so the surgeon can view the area with a laparoscope. The LP is as effective in treating patients with prostate cancer as open su ...
View and Download RFA
View and Download RFA

... Correlative research around either clinical trials of novel agents or strategies or standard of care. ...
Pathology – Lecture 44: Prostatitis and BPH 11/29/12 Prostatitis
Pathology – Lecture 44: Prostatitis and BPH 11/29/12 Prostatitis

... o Lower urinary tract symptoms (LUTS) or prostatism  Clinical manifestations  Constricts flow of urine  o Urinary frequency o Urgency o Hesitancy o Incomplete bladder emptying o Straining o Decreased force of stream o Dribbling  Complex is nonspecific and can be caused by neurogenic bladder, bla ...
Benign Prostatic Hyperplasia (BPH)
Benign Prostatic Hyperplasia (BPH)

... The material presented here is being made available by the American Academy of Family Physicians for educational purposes only. This material is not intended to represent the only, nor necessarily best, methods or procedures appropriate for the medical situations discussed. Rather, it is intended to ...
The need for a lower total PSA cut-off value with PSA
The need for a lower total PSA cut-off value with PSA

... most common form of malignancy in Europeans, with its incidence increasing more than with any other cancer over the last 20 years. According to WHO, about 190,000 new cases occur each year. Prostatespecific antigen (PSA) is the serum biomarker most widely used for early detection of prostate cancer ...
Hormone Therapy for Prostate Cancer Patient Information Leaflet
Hormone Therapy for Prostate Cancer Patient Information Leaflet

... You will be seen regularly by both your General Practitioner and members of the Urology team here at the Queen Elizabeth Hospital to monitor the response of your cancer to treatment, you will have regular blood tests to check your PSA level which is a protein made by prostate tissue, as this is usua ...
The Lifetime Risk of Developing Prostate Cancer in White and Black
The Lifetime Risk of Developing Prostate Cancer in White and Black

... in the computation remain stationary over the baby’s lifetime. Lifetime risk does not take into account individual risk profiles but reflects the average condition in the population ...
BME 301
BME 301

... Facilities exist for treatment and follow-up When disease prevalence is high enough to justify effort and costs of screening ...
PCA3: A New Prostate Cancer Biomarker? July 2012
PCA3: A New Prostate Cancer Biomarker? July 2012

... benefit. Herein lies the true issue of the problem, which is not the test itself. The American Cancer Society in its response to the recommendation notes: “…we are concerned that many men will be harmed by undergoing screening that leads to detection and treatment of prostate cancers that would neve ...
2017 MRI Prostate.indd
2017 MRI Prostate.indd

... This CME activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education thru the joint providership of The Institute for Medical Studies (IMS) and Northwest Imaging Forums, Inc. IMS is accredited by the ACCM ...
Management of Biochemically Recurrent Prostate Cancer Following
Management of Biochemically Recurrent Prostate Cancer Following

... cancer leads to the identification of men with a PSA-only (bio© Managed Care & chemical) recurrence, for which there are no symptoms or signs Healthcare Communications, LLC of locally recurrent or metastatic disease. The definition of PSA recurrence is dependent upon the type of initial local therap ...
Coding Region of NKX3.1, a Prostate-Specific
Coding Region of NKX3.1, a Prostate-Specific

... chromosome 8. This unbroken map spanned 45 cM in males and 79 cM in females and included 14 DNA markers. These markers in cluded, among others, three genes (MSR, LPL, and NEFL) that were previously assigned to 8p. We used these three genes because they mapped within the 8p21-22 region of chromosome ...
PROSTATE CANCER: LOCAL CONTROL, SURVIVAL AND HIGH
PROSTATE CANCER: LOCAL CONTROL, SURVIVAL AND HIGH

... treatment of low-risk clinically localized prostate ca. during an 8 y. period, no improvement in biochemical FFF was noted with the higher doses. The overall 5 y. rate of freedom from biochemical failure is consistent with that reported by others with standard and escalated EBRT doses. Prospective r ...
Understanding Prostate Cancer
Understanding Prostate Cancer

... If Prostate Cancer Progresses After Local Treatment Prior to beginning treatment for localized cancer, such as radical prostatectomy or radiation therapy, it may be possible for a physician to make his or her assessment of the anticipated success of specific treatments ...
Precise, Minimally Invasive Prostate Cancer
Precise, Minimally Invasive Prostate Cancer

... In prostate cancer treatment, millimeters matter. Nerve fibers and blood vessels are attached to the prostate gland. To spare these nerves, they must be delicately separated from the prostate before its removal. In comparison, radiation beam treatment can vary by several millimeters. In one study of ...
< 1 ... 3 4 5 6 7 8 9 10 11 ... 16 >

Prostate cancer screening

Prostate cancer screening is an attempt to identify individuals with prostate cancer in a broad segment of the population—those for whom there is no reason to suspect prostate cancer. There are currently two methods used: One is the digital rectal examination (DRE), in which the examiner inserts a gloved, lubricated finger into the rectum to examine the adjoining prostate. The other is the prostate-specific antigen (PSA) blood test, which measures the concentration of this molecule in the blood.The United States Preventive Services Task Force (USPSTF) recommended against PSA screening in healthy men finding that the potential risks outweigh the potential benefits. Guidelines from the American Urological Association, and the American Cancer Society recommend that men be informed of the risks and benefits of screening. The American Society of Clinical Oncology recommends screening be discouraged in those who are expected to live less than ten years, while in those with a life expectancy of greater than ten years a decision should be made by the person in question based on the potential risks and benefits. In general, they conclude that based on recent research, ""it is uncertain whether the benefits associated with PSA testing for prostate cancer screening are worth the harms associated with screening and subsequent unnecessary treatment.""
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report